• 226%

    C-Peptide

    Distinguishing Insulinomas from exogenous insulin administration

    C-Peptide

    Distinguishing Insulinomas from exogenous insulin administration
  • 226%

    C1 Esterase Inhibitor

    Nil
  • 226%

    CA 125

    Evaluating respone to ovarian cancer therapy and predicting recurrent ovarian cancer or intraperitoneal tumor

    CA 125

    Evaluating respone to ovarian cancer therapy and predicting recurrent ovarian cancer or intraperitoneal tumor
  • 227%

    CA 15.3

    Predicting early recurrence in women treated for Carcinoma Breast

    CA 15.3

    Predicting early recurrence in women treated for Carcinoma Breast
  • 227%

    CA 19-9

    Monitoring the response to treatment and recurrence of Pancreatic Cancer

    CA 19-9

    Monitoring the response to treatment and recurrence of Pancreatic Cancer
  • 227%

    Calcitonin-IHC

    Please send 1-2 representative H&E stained slides along with representative FFPE blocks.

    Calcitonin-IHC

    Please send 1-2 representative H&E stained slides along with representative FFPE blocks.
  • 227%

    CALCIUM – URINE

    Calcium in urine

    CALCIUM – URINE

    Calcium in urine
  • 228%

    CALCIUM IONISED (CA++)

    Accurate assessment of calcium especially in the presence of high protein concentrations, hyperparathyroidism or hypoparathyroidism

    CALCIUM IONISED (CA++)

    Accurate assessment of calcium especially in the presence of high protein concentrations, hyperparathyroidism or hypoparathyroidism
  • 228%

    Calcium; Total

    Assessment of parathyroid function test

    Calcium; Total

    Assessment of parathyroid function test